Topicals, generic [Regulatives / Guidelines]

posted by ioanam – Romania, 2013-04-01 09:51 (4832 d 23:08 ago) – Posting: # 10318
Views: 28,457

Thank you very much for your responses.

I consider that EMA must present a clear guideline for this type of products in order to have the same procedure in all EU countries because in some countries is still possible to obtain MA as a well established use product, while other authorities requires more and more trials. This is not ok.

We are all equal, but some are more equal than others (Sorry for this satirical quote adapted to this situation). :yes:

Wish you a beautiful week,
Ioana

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
130 visitors (0 registered, 130 guests [including 22 identified bots]).
Forum time: 08:59 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5